Cargando…

A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19

Background and Objectives: Coronavirus disease 2019 (COVID-19) has caused global pandemics in the last 3 years, and the development of new therapeutics is urgently needed. This study aimed to assess the safety, tolerated, and prolonged retention of recombinant protein trefoil factor 2 (TFF2)- interf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Zhai, Guanxing, Fu, Weihui, Zhang, Xiaoyan, Xu, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790930/ https://www.ncbi.nlm.nih.gov/pubmed/36578554 http://dx.doi.org/10.3389/fphar.2022.1063106

Ejemplares similares

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19
por: Fu, Weihui, et al.
Publicado: (2020)

An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19
por: Fu, Weihui, et al.
Publicado: (2020)

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
por: Jain, Mamta K., et al.
Publicado: (2022)

IFNγ-dependent silencing of TFF1 during Helicobacter pylori infection
por: Eletto, D., et al.
Publicado: (2022)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial
por: Cheong, Pui Kuan, et al.
Publicado: (2022)

A double-blind, randomized, placebo-controlled, single-center clinical trial of jiaotaiwan for the treatment of insomnia symptoms caused by disharmony of the heart and kidney
por: Xia, Nengzhi, et al.
Publicado: (2022)

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Ni, Wenjing, et al.
Publicado: (2023)

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022)

Efficacy and safety of total glucosides of paeony in the treatment of recurrent aphthous ulcers: a single-center, double-blind, randomized, placebo-controlled clinical trial
por: Liu, Zijian, et al.
Publicado: (2023)

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Xu, Xuan, et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
por: Backer, Vibeke, et al.
Publicado: (2021)

Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
por: Lee, Su Won, et al.
Publicado: (2022)

Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
por: Newman, Joseph V., et al.
Publicado: (2018)

Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
por: Ishibashi, Yuko, et al.
Publicado: (2017)

Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial
por: Jiang, Rongmeng, et al.
Publicado: (2020)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma
por: Lv, Yubao, et al.
Publicado: (2018)

Validation of the DNA Methylation Landscape of TFF1/TFF2 in Gastric Cancer
por: Qian, Ze, et al.
Publicado: (2022)

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial
por: Lyu, Tianyi, et al.
Publicado: (2023)

Anti-Wrinkle Efficacy of Edible Bird’s Nest Extract: A Randomized, Double-Blind, Placebo-Controlled, Comparative Study
por: Kim, Hyung Mook, et al.
Publicado: (2022)

Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study
por: Singh, Priyam, et al.
Publicado: (2022)

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
por: Du, Kangjia, et al.
Publicado: (2022)

Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population
por: Jin, Eun-Heui, et al.
Publicado: (2015)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
por: Carroll, F. Ivy, et al.
Publicado: (2018)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study
por: Gu, Si-Chun, et al.
Publicado: (2022)

Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
por: Wang, Yuanping, et al.
Publicado: (2022)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
por: Montuschi, Paolo, et al.
Publicado: (2018)

Efficacy and safety of traditional Chinese medicine external washing in the treatment of postoperative wound of diabetes complicated with anal fistula: Study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
por: Kang, Jian, et al.
Publicado: (2022)

Does pomegranate extract supplementation improve the clinical symptoms of patients with allergic asthma? A double-blind, randomized, placebo-controlled trial
por: Hosseini, Seyed Ahmad, et al.
Publicado: (2023)

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study
por: Huang, Kai, et al.
Publicado: (2022)

Efficacy and safety of the herbal formula Naesohwajung-tang for functional dyspepsia: a randomized, double-blind, placebo-controlled, multi-center trial
por: Ha, Na-Yeon, et al.
Publicado: (2023)

In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma
por: Lemmel, Solveig, et al.
Publicado: (2022)

Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial
por: Shi, Dan-Dan, et al.
Publicado: (2017)

The Effects of Vitamin D Supplementation on Signaling Pathway of Inflammation and Oxidative Stress in Diabetic Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Haddad Kashani, Hamed, et al.
Publicado: (2018)

The Efficacy and Safety of a Fixed Combination of Chinese Herbal Medicine in Chronic Urticaria: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Yang, Sien-Hung, et al.
Publicado: (2018)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Liu, Ningning, et al.
Publicado: (2020)

Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
por: Lee, Ju Hyun, et al.
Publicado: (2020)

Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
por: Zhang, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1fsf6icuhodb11gg262jvllf63